Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

LEUCOVORIN CALCIUM

All products: general benefit

Leucovorin Calcium · DIN 02170493 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Leucovorin Calcium · DIN 02170493 Manufacturer: Wyeth Pharmaceuticals; listing date 1999-01-07 Health Canada: Marketed since 2012-03-02 · brand LEDERLE LEUCOVORIN · ATC V03AF03 CALCIUM FOLINATE · form Tablet · route Oral · ingredients LEUCOVORIN (LEUCOVORIN CALCIUM) 5 MG · company Pfizer canada ulc · schedule Prescription
Check this DIN again · Health Canada product record

Ministry pays: $1.8388 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44146 · Verify on the e-Formulary ↗ (DIN 02170493)

Source record
DIN 02170493: Leucovorin Calcium Raw flags: sec3=Y Item: 880800015; group id 882; item number 2123; lccId None; manufacturer id WAY Source form: Tab; strength: 5mg Recorded listing: General benefit Source prices (unrounded): $7.3552; ministry $1.8388 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02170493 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44146
Interchangeable products
Jamp Leucovorin · DIN 02548208 · $1.8388 Mint-Leucovorin · DIN 02496828 · $1.8388 Riva Leucovorin · DIN 02493357 · $1.8388
Shortage status: resolved shortage (ended 2021-07-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02170493
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (88:08 Vitamin B) and how they are covered

Matched class: 88:08 Vitamin B

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): CYANOCOBALAMIN, FOLIC ACID 88:08 Vitamin B

CYANOCOBALAMIN

· 5 products · Listed, not a benefit (1), General benefit (4) · strengths: 1mg/mL · Inj Sol-10mL Pk

FOLIC ACID

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 5mg · Tab

NICOTINIC ACID

· 2 products · Listed, not a benefit · strengths: 50mg · Tab

THIAMINE HCL

· 2 products · Listed, not a benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada · strengths: 50mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 88:08
Full class listing Related classes: 88:12 Vitamin C, 88:16 Vitamin D, 88:28 Multivitamins Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS LEDERLE LEUCOVORIN (calcium folinate) is indicated for:  diminishing the toxicity and counteracting the effect of impaired methotrexate elimination.  treatment of megaloblastic anemias due to folate deficiency, as in sprue, nutritional deficiency, megaloblastic anemias of pregnancy and infancy. 1.1 Pediatrics Pediatrics (< 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use (see 7 WARNINGS AND PRECAUTIONS, 7.1.3 Pediatrics). 1.2 Geriatrics Geriatrics: Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness (see 7 WARNINGS AND PRECAUTIONS, General and 7.1.4 Geriatrics). https://pdf.hres.ca/dpd_pm/00067652.PDF PM date: OCT 25, 1996 Source product: LEDERLE LEUCOVORIN; DIN 02170493; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.